EMEA-001475-PIP03-17-M01

Key facts

Active substance
Maralixibat chloride (LUM001)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0409/2019
PIP number
EMEA-001475-PIP03-17-M01
Pharmaceutical form(s)
Oral liquid
Condition(s) / indication(s)
Treatment of Progressive Familial Intrahepatic Cholestasis
Route(s) of administration
Oral use
Contact for public enquiries
SFL Regulatory Services GmbH

Tel.  +41 613667160
E-mail: j.gaudias@sfl-services.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating